The utility of whole exome sequencing in prenatal diagnosis : 1-2
Validation of non-invasive prenatal diagnosis (NIPD) of multiple single gene disorders for clinical implementation : 1-3
Non-invasive prenatal diagnosis (NIPD) for cystic fibrosis – beyond paternal mutation exclusion : 1-4
Haplotype-assisted noninvasive prenatal diagnosis of common monogenic diseases using massively parallel sequencing of plasma cell-free DNA : 1-5
Expansion of assessment methods to measure effects of fetal spina bifida induction and repair in the fetal lamb : 2-1
Connexin 43 is overexpressed in human fetal membrane defects after fetoscopic surgery : 2-2
BOOSTB4 – A clinical study on pre- and/or postnatal stem cells transplantation for treatment of osteogenesis imperfecta : 2-3
External quality assessment of testing cell free DNA for fetal sex determination : 3-1
Realization of the Belgian Prenatal Microarray (BEMAPRE) database and update of the Belgian reporting approach : 3-2
Maternal cell contamination may significantly confound the interpretation of prenatal NGS testing : 3-3
Chromosomal microarray analysis in fetuses with aberrant right subclavian artery : 4-1
Early sonographic evaluation of facial integrity in dystrophic fetuses via 3D-ultrasound : 4-2
Antral follicle size as a first trimester predictor of fetal trisomy : 4-3
International Variability in 47,XXY (Klinefelter Syndrome) Phenotype : 5-1
A large prospective study of the neurodevelopmental outcome in prenatally diagnosed males with 47, XXY : 5-2
Randomized controlled trial comparing preimplantation genetic screening utilizing next generation sequencing to standard morphologic assessment for embryo selection and single embryo transfer after vitrification : 5-3
Clinical experience with multigene carrier panels : 5-4
Aneuploidy screening in polarbodies is superior to trophectoderm analysis as it detects the meiotic errors and circumvents decision making of mosaic embryo results : 5-5
The timing of reproductive genetic counseling is the most important factor influencing acceptance of expanded carrier screening : 5-6
Confined placental mosaicism: Re-evaluation of pregnancy characteristics and influence on fetal growth : 6-1
The development of a placental murine xenograft model : 6-2
Increased risk for pregnancy loss, true fetal mosaicism and uniparental disomy associated with rare autosomal aneuploidies identified during non-invasive prenatal testing : 6-4
Incremetal yield of genomic microarray in early growth restricted fetuses over karyotyping : 6-5
Discordant hypoxic condition and oxidative stress in placental shares of monochorionic twins with selective intra-uterine growth restriction : 6-6
Clinical implementation of NIPT: Understanding the role of non-specialist provider education : 7-1
Ensuring high quality NIPD and NIPT for the patient : 7-2
Odds of being affected given a positive result (OAPR) in cell-free DNA screening for fetal autosomal and sex chromosome aneuploidy: Data from four cytogenetic laboratories : 7-3
Fetal aneuploidy screening results in maternal plasma samples redrawn due to insufficient fetal cfDNA in the initial sample : 7-4
Decisional regret in women receiving high-risk or inconclusive results from non-invasive prenatal genetic screening : 7-5
Plasma DNA tissue mapping to pinpoint site of occult maternal malignancy identified by NIPT : 7-6
Correlation between fetal autopsy and prenatal diagnosis: a systematic review of literature : 8-1
Head circumference of fetuses with congenital heart disease decreases in the second half of pregnancy : 8-2
Fetal neuronal migration disorder between 15 and 26 weeks of gestation : 8-3
Diagnostic accuracy of congenital heart defects after referral from routine ultrasound screening : 8-4
From fetal dysmorphology to exome sequencing: The diagnostic performance for making a perinatal genetic diagnosis : 8-5
The effect of a decision aid on informed decision making in the era of non-invasive prenatal testing: A randomized controlled trial : TA-1
An integrated human/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome : TA-2
Amniotic fluid transcriptomic changes in fetuses with myelomeningocele : TA-3
A bespoke non-invasive prenatal diagnostic (NIPD) Service for paternal Mutation and de novo Recurrence Exclusion : TA-4
Genomes and pregnancy, the gap study: Providing choice of fetal genomic results to women having prenatal diagnosis : TA-5
BACs-on-beads as a diagnostic platform for the rapid aneuploidy and microdeletion/microduplication detection in amniocytes: experience of a prenatal diagnosis center : P-2
Prenatal diagnosis of 22q11.2 microduplication syndrome: report of three cases : P-3
Correlation between biochemical anti-angiogenic marker and Doppler study of fetal vessels in preeclampsia with or without IUGR : P-6
A national survey of intrauterine blood transfusion (IUT) in Japan : P-7
Clinical implementation of NIPS by an onshore laboratory in Sydney Australia – new experiences in the future of first trimester prenatal management : P-8
Aberrant right subclavian artery: correlation between fetal and neonatal abnormalities : P-9
How many carriers are you missing?: the value of expanded carrier screening : P-10
Test sequentially or test concurrently? An analysis of clinical approaches to expanded carrier screening : P-11
The usefulness of interphase fluorescence in situ hybridization (iFISH) for prenatal diagnosis : P-12
Prenatal cell free (cf)DNA screening in low risk pregnancies through primary providers: a demonstration project : P-14
Prenatal diagnosis of congenital heart disease by ultrasound and chromosomal microarray analysis : P-16
Prenatal diagnosis of interstitial deletion 11q associated with abnormal ultrasound findings : P-17
Russell–Silver syndrome: prenatal and placental findings : P-19
Maternal uniparental disomy for chromosome 6 in a patient with IUGR, ambiguous genitalia, and persistent Mullerian structures : P-20
Neu Laxova syndrome caused by a mutation in PHGDH in a Pakistani family : P-21
The information and psychosocial support provided during decision-making by pregnant women who are incidentally diagnosed with fetal abnormalities in Japan – an online survey : P-22
Genome-wide non-invasive prenatal test can detect chronic myeloid leukemia caused by translocation t(9;22)(q34;q11.2) with deletions at the translocation breakpoints : P-23
Maternal incidental findings during non-invasive prenatal testing for fetal aneuploidies : P-24
Side-by-side comparison of the NIFTY test and IONA test for non-invasive prenatal testing (NIPT) with on-going follow up of outcomes : P-25
Gene identification in fetal malformation phenotypes : P-26
Chromosomal microarray analysis on fetuses with ultrasound anomalies : P-27
Expanding noninvasive prenatal testing (NIPT) for screening of unbalanced translocations : P-30
Frequencies of total uniparental isodisomy and triploidy in a series of oligo-SNP array analyses of products of conception (POC) and amniocytes : P-31
The impact of maternal factors on the measurement of first trimester maternal serum placental growth factor and α -fetoprotein : P-32
Abnormal ultrasound and increased yield of abnormal results with genome-wide cfDNA analysis : P-33
Early amniocentesis for diagnosis of trisomy 18 in the setting of lower urinary tract obstruction and abnormal non-invasive prenatal screening : P-34
Identification of Greenberg skeletal dysplasia in a fetus with hydrops and severe micromelia : P-35
Trisomy 9 mosaicism in monochorionic twins manifesting with discordant phenotypes : P-36
Assessment of a rapid aneuploidy diagnosis by the BACs-on-beads assay during late pregnancy : P-37
Non-invasive prenatal testing in a mixed-risk population using massively parallel sequencing : P-38
The impact of frozen storage on the measurement of first trimester maternal serum markers for Down syndrome screening : P-39
Enquiring clients' values as part of counseling for prenatal anomaly screening: an exploratory video-observational study : P-41
Association studies of vasoactive genes and preeclampsia in Taiwan : P-44
A case report: Prenatal diagnosis in a fetus with α -thalassemia and complete trisomy 9 : P-45
Prenatal diagnosis of thalassemia: sixteen-year experience at a mainland Chinese hospital : P-46
MicroRNA profiling in acute chorioamnionitis using archival placental tissue : P-48
Contribution of NIPT in case of ultrasonic malformations : P-49
Self-perception of people with Down syndrome in Japan: results from a nationwide survey : P-50
Introduction of non-invasive prenatal testing (NIPT) as a first-tier screening test: a survey among Dutch midwife-counselors : P-51
Developing standard maternal and fetal adverse event severity grading criteria: building the framework obstetric trials, including fetal therapies : P-52
A rare case of fetal Noonan-like syndrome caused by de novo splicing mutation within the CBL gene : P-58
Genome wide detection of chromosomal gains and losses greater than 7Mb by cfDNA analysis : P-59
Clinical follow-up study of PraenaTest®-preliminary results of a german multicenter post market clinical follow-up study : P-60
Case report: Prenatal diagnosed rare trisomy 16 mosaicism : P-61
Prenatal clinical and molecular (epi-) genetic diagnosis of Beckwith–Wiedemann syndrome: time to shift gears? : P-62
Responsible implementation of expanded carrier screening: recommendations of the European Society of Human Genetics : P-63
Radiographic pelvimetry: evaluation of radiation dose and image quality : P-65
Non-invasive prenatal test reveals fetus with 5q35.1q35.3 deletion and 10p15.3p13 duplication derived from father's balance translocation 46,XY,t(5;10)(q35.1;p13) : P-66
Two incidental findings on recurrent miscarriage using SNP array: Dystrophin gene deletion in products of conception and de novo microduplication including RPS6KA3 in CVS : P-68
A new software application for recording data pertaining to invasive prenatal testing for a nationwide registry in Japan : P-69
Outcome of monosomy X pregnancies according to the parental origin of the X chromosome : P-71
Evaluation of carotid artery intima media thickness(CIMT) and SCUBE1 concentration in patients having recurrent pregnancy loss : P-72
Noninvasive prenatal screening for sex chromosome aneuploidy: clinical experience in a genetics referral center : P-73
Presacral echogenic mass during mid-trimester scanning: is it benign : P-75
Relationship between polycystic ovarian syndrome and subsequent abortion: a nationwide population-based study : P-76
The role of preterm placental calcification on assessing risks of stillbirth : P-77
Non-invasive prenatal testing by digital counting of fluorescently labeled DNA molecules : P-78
Routine use of chromosomal microarray as standard first-tier approach in high risk pregnancies : P-79
Taking NIPT to the next level: detection of fetal trisomy 21 based on quantitative real-time PCR : P-80
Validation of a novel array CGH-based non-invasive prenatal test for trisomy 21 : P-81
Comparing fetal fractions after centrifugation or microfluidic extraction of maternal blood plasma : P-82
Recent bioinformatics advances of non-invasive prenatal testing (NIPT) to enhance detection of 22q11.2 deletion syndrome : P-83
Psychological and ethical issues in prenatal diagnosis : P-84
Counseling using posttest risks following non-invasive prenatal screening; the need for caution : P-86
Cardiac axis as a first trimester marker of fetal aneuploidy and cardiac defects : P-87
Performance evaluation of NIPT in detection of chromosomal copy number variants using low-coverage whole-genome sequencing of plasma DNA : P-90
Structural chromosome abnormalities play a role in the etiology of miscarriages : P-91
Prenatal diagnosis of sonographic abnormalities using rapid whole exome sequencing : P-92
Trends in Down's syndrome live births and prenatal diagnoses in Latvia : P-93
Incidence of placental chromosomal mosaicism in miscarriages : P-94
Prenatal whole genome SNP array diagnosis: relevance of incidental findings in pregnancies with and without ultrasound anomalies : P-95
Low incidence of abnormal cell free fetal DNA screening in the presence of isolated sonographic soft markers for fetal aneuploidy: one center's experience : P-96
Toward an ethical framework for prenatal whole exome sequencing : P-97
Long term outcomes of congential heart disease: a systematic review of literature : P-98
Updated experience with cell free fetal DNA testing in Argentina : P-99
Prenatal diagnosis of microdeletion and microduplication in fetal growth restriction : P-100
Analysis of four cases of unexpected NIPT results: false positive, false-negative and non-reportable cases : P-101
Maternal plasma and placenta microRNAs expression profiling of preeclamptic pregnancies by microarray technology : P-102
Prenatal diagnosis of chromosome abnormalities: a 5-year institution experience : P-103
Features detection of children with congenital malformations and chromosomal abnormalities in the Republic of Kazakhstan, Astana City : P-108
Genetic study of a fetus with 9p direct duplication deletion syndrom : P-110
Application of single nucleotide polymorphism-based arrays analysis in prenatal diagnosis of fetus with de novo derivative chromosome : P-112
Clinic analysis of 63 cases of amniotic fluid mosaicism : P-114
Clinical value of fetal increased nuchal fold in screening fetal chromosomal abnormalities during the second trimester : P-115
Correlation of chromosomal abnormalities with abnormal amniotic fluid volume : P-116
Genetic analysis of 109 patients with primary amenorrhea : P-117
Karyotype analysis and single nucleotide polymorphism-based arrays analysis of fetuses with increased nuchal translucency : P-119
Karyotype analysis of 96 children with growth retardation : P-120
Karyotype analysis of 150 males with azoospermia : P-121
Karyotyping for 85 children with hypospadias : P-122
Prenatal diagnosis of a 1p36.3 microdeletion in a fetus with heart defects : P-123
Single nucleotide polymorphism-based arrays analysis of fetuses with fetal growth restriction : P-124
Whole genome evaluation of all 24 chromosomes explains unusual NIPT results and suggests additional risks : P-125
Bed to bed management of gastroschisis: predictors of prognosis : P-126
Crown-rump length audit plots with the use of operator-specific PAPP-A and ß -HCG median MoM : P-127
Patents and their influence on the development of non-invasive prenatal testing : P-128
Classification and reproductive relevance of unidentified genetic risk factors in prenatal care : P-129
Study of concentration of amniotic fluid alpha-fetal protein in thalassemia fetus : P-130
Prenatally genetic analysis on two fetuses with Miller–Dieker syndrome : P-131
Improved assay performance of SNP array over conventional karyotyping in analyzing products of conception : P-132
10q26 deletion syndrome: two new cases and a review of the literature : P-133
Improved identification for 5p deletion syndrome and partial trisomy 11q presented in a fetus by SNP array : P-134
Application of SNP array in the accurate identification of Angelman syndrome (Type 1) : P-135
Unexpected diagnosis of systemic primary carnitine deficiency in a child: An implication from a large region of homozygosity : P-136
Association of maternal plasma fetal DNA fraction with pregancy-hypertension and pre-eclampsia in Chinese population : P-138
Prenatal SNP array in fetuses with isolated orofacial clefts : P-138
Cost effectiveness of non-invasive prenatal screening (NIPS) as a first trimester screening tool for trisomy 21 : P-141
Posterior fossa markers in first trimester chromosomally abnormal fetuses : P-142
New insight in the interpretation of microduplication of KAL1 gene : P-145
Abnormal SNP microarray in cases with first trimester ultrasound abnormalities : P-146
Development of a novel targeted assay for non-invasive prenatal testing of fetal trisomies exhibits near-diagnostic accuracy : P-147
Development of bead-based suspension array technology for the diagnosis of hereditary hearing loss : P-148
First trimester QUAD screening for prenatal aneuploidy and preeclampsia risk assessment : P-149
First experiences: Preimplantation Genetic Diagnosis (PGD) Center, MGZ Munich : P-150
Fetal cardiac interventions: report of 10-year experience in a specialized tertiary centre : P-151
Comparison of two test systems for sFlt-1 and PlGF – diagnostic accuracy for preeclampsia-related outcomes : P-153
Limitations and pitfalls of non-invasive cell-free fetal DNA aneuploidy testing in a clinical practice : P-154
Clinical validation of a non-invasive prenatal test for genome-wide detection of fetal chromosomal abnormalities : P-157
Implementation of a targeted enrichment method for the detection of microdeletion and microduplication syndromes for NIPT : P-158
Accuracy and reproducibility of fetal fraction measurement using quantitation at polymorphic loci with microarray : P-159
A novel NIPT approach based on the methylation differences between maternal and fetal DNA : P-160
Non-invasive prenatal testing for genome-wide detection of fetal copy number variants reveals aneuploidies in patients with repeated cell-free DNA testing failures : P-161
Clinical implementation of routine screening for fetal trisomies (21, 13, 18, and sex chromosomes) with cell-free DNA analysis in an intermediate risk group (1:700 to 1:301) : P-163
Survey of long survival cases of thanatophoric dysplasias : P-164
Fetal fraction reference material generation for non-invasive prenatal testing using highly characterized Ashkenazim mother and son cell lines : P-165
There is a different learning curve for open and fetoscopic spina bifida surgery – a systematic review and meta-analysis : P-166
Performance evaluation and clinical implementation of the NeoBona test, a new paired-end MPSS approach for cfDNA-based prenatal screening of common chromosome aneuploidies : P-168
Validation of a targeted, multiplex PCR-based NIPT in an international multi-centre study : P-169
Antenatal sonographic findings of extrahepatic vitelline vein aneurysm : P-170
Fetal reduction after multiple pregnancies: Implications and considerations for non invasive prenatal testing : P-171
Continuous amnioinfusion via a subcutaneously implanted port system with PPROM and anhydramnios <28 + 0 weeks of gestation: An international prospective randomized trial : P-172
Leveraging fragment size information from targeted analysis of cell free DNA for non-invasive prenatal detection of fetal aneuploidies : P-173
Altered cervical collagen concentration by dinoprostone during cervical ripening in postterm pregnancies, compared with oxytocin : P-174
Prenatal diagnosis of isolated fetal gallbladder duplication associated with chromosomal mutation (46,X,t(X;10(p11.2;Q24.3) : P-175
Prenatal diagnosis of a rare, autosomal recessive disorder by combining genome wide array analysis and whole exome sequencing : P-176
Analysis of the application of FISH combination with karyotyping in prenatal diagnosis : P-177
Clinical significance of 3D HDlive silhouette/flow in neurosonoembryology and fetal neurosonography : P-178
The host immune response to a mildly immunogenic extracellular matrix scaffold cannot be modulated by co-cultured mesenchymal stem cells derived from the amniotic fluid : P-179
Technical assessment of noninvasive prenatal diagnosis of monogenic diseases with droplet digital PCR : P-180
Is it unethical (not) to transfer an aneuploid embryo? : P-181
Microarray abnormalities in prenatally diagnosed omphaloceles : P-182
Two and a half years' experience of a newly established prenatal genetics clinic in Japan: What are the problems that we need to consider in the clinical practice of prenatal testing/diagnosis in Japan? : P-183
Beckwith–Wiedemann syndrome in prenatally diagnosed omphaloceles : P-186
Prenatal diagnosis of orofacial clefting necessitates a gestational age-based approach : P-187
Exploring the clinical value of whole genome screening in non invasive prenatal screening (NIPS) : P-188
SNP-based chromosomal microarrays identify microdeletion syndromes in miscarriage samples : P-189
Performance of a SNP-based NIPT in screening for five clinically significant microdeletions in a large clinical cohort : P-192
Biomimetic reference materials for NIPT assays : P-196
Noninvasive prenatal testing for trisomy 21, 18, 13 and sex chromosomal aneuploidies – first report on 1380 pregnancies from Iran : P-197
Noninvasive prenatal screening for common aneuploidies in a Canadian province: A cost-effectiveness analysis : P-198
Preimplantation genetic diagnosis by haplotype enabled allele identification on whole-genome-amplification product from single biopsy : P-199